← Back to Search

N/A

EC with nicotine for Long QT Syndrome

N/A
Waitlist Available
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in qtc 5 minutes before and 5 minutes after cigarette use
Awards & highlights
No Placebo-Only Group

Summary

This trial studies how using electronic and tobacco cigarettes with different nicotine levels affects heart function. Researchers will measure heart activity to see how it impacts the heart's electrical resetting process.

Eligible Conditions
  • Long QT Syndrome
  • Sudden Cardiac Death

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in tpe 5 minutes before and 5 minutes after cigarette use
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in tpe 5 minutes before and 5 minutes after cigarette use for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Tpe
Tpe/QT
Tpe/QTc
Secondary study objectives
QT
QTc

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Group I: Non-userExperimental Treatment3 Interventions
Non- users will use, in a randomized, crossover fashion with a 4 week washout, an 1) EC with nicotine, 2) EC without nicotine, and 3) an empty EC (control)
Group II: Chronic TC smokerExperimental Treatment3 Interventions
Chronic TC smokers will use, in a randomized, crossover fashion with a 4 week washout, a 1) TC with nicotine (own brand), 2) research TC with very low level nicotine, and 3) a straw (control)
Group III: Chronic EC userExperimental Treatment3 Interventions
Chronic EC users will use, in a randomized, crossover fashion with a 4 week washout, an 1) EC with nicotine, 2) EC without nicotine, and 3) an empty EC (control)

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,564 Previous Clinical Trials
10,262,523 Total Patients Enrolled
Tobacco Related Disease Research ProgramOTHER
26 Previous Clinical Trials
26,285 Total Patients Enrolled

Media Library

EC with nicotine (N/A) Clinical Trial Eligibility Overview. Trial Name: NCT03916341 — N/A
Long QT Syndrome Research Study Groups: Non-user, Chronic EC user, Chronic TC smoker
Long QT Syndrome Clinical Trial 2023: EC with nicotine Highlights & Side Effects. Trial Name: NCT03916341 — N/A
EC with nicotine (N/A) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03916341 — N/A
~18 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top